High throughput selection of effective serodiagnostics for Trypanosoma cruzi infection

PLoS Neglected Tropical Diseases

Volumn 2, Issue 10, 2008, Pages

  Cooley, Gretchen ^a   Etheridgel, R Drew ^a   Boehlke, Courtney ^a   Bundy, Becky ^a   Weatherly, D Brent ^a   Minning, Todd ^a   Haney, Matthew ^a   Postan, Miriam ^b   Laucella, Susana ^b   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b Instituto Nacional de Diagnostico e Investigacion de la Enfermedad de Chagas Dr Mario Fatala Chaben   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; MICROORGANISM PROTEIN; PARASITE ANTIBODY; RECOMBINANT PROTEIN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG MONITORING; DRUG TREATMENT FAILURE; HIGH THROUGHPUT SCREENING; HOST PARASITE INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MAMMAL; NONHUMAN; OUTCOME ASSESSMENT; PARASITE SERODIAGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SAMPLING; SEROLOGY; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; EVALUATION; FEMALE; GENETICS; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; PARASITOLOGY;

ADULT; ANTIBODIES, PROTOZOAN; CHAGAS DISEASE; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MIDDLE AGED; PROTOZOAN PROTEINS; SEROLOGIC TESTS; TRYPANOSOMA CRUZI;

EID: 56149088543     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000316     Document Type: Article

References (46)

1. Cohen JE, Gurtler RE (2001) Modeling household transmission of American trypanosomiasis. Science 293: 694-698.
2. Young C, Losikoff P, Chawla A, Glasser L, Forman E (2007) Transfusion-acquired Trypanosoma cruzi infection. Transfusion 47: 540-544.
3. Chagas disease after organ transplantation-Los Angeles, California, 2006. MMWR Morb Mortal Wkly Rep 55: 798-800.
4. Munoz J, Portus M, Corachan M, Fumado V, Gascon J (2007) Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg 101: 1161-1162.
5. Aguilar HM, Abad-Franch F, Dias JC, Junqueira AC, Coura JR (2007) Chagas disease in the Amazon Region. Mem Inst Oswaldo Cruz 102 Suppl 1: 47-56.
6. Shikanai-Yasuda MA, Marcondes CB, Guedes LA, Siqueira GS, Barone AA, et al. (1991) Possible oral transmission of acute Chagas disease in Brazil. Rev Inst Med Trop Sao Paulo 33: 351-357.
7. Benchimol Barbosa PR (2000) The oral transmission of Chagas' disease an acute form of infection responsible for regional outbreaks. Int J Cardiol 112: 132-133.
8. Nicholls RS, Cucunuba ZM, Knudson A, Florez AC, Montilla M, et al. (2007) [Acute Chagas disease in Colombia: A rarely suspected disease. Report of 10 cases presented during the 2002-2005 period]. Biomedica 27 Suppl 1: 8-17
9. Pirard M, Iihoshi N, Boelaert M, Basanta P, Lopez F, et al. (2005) The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 45: 554-561.
10. Salomone OA, Basquiera AL, Sembaj A, Aguerri AM, Reyes ME, et al. (2003) Trypanosoma cruzi in persons without serologic evidence of disease, Argentina. Emerg Infect Dis 9: 1558-1562.
11. Avila HA, Pereira JB, Thiemann O, De PE, DeGrave W, et al. (1993) Detection of Trypanosoma cruzi in blood specimens of chronic chagasie patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: Comparison with serology and xenodiagnosis. J Clin Microbiol 31: 2421-2426.
12. Castro AM, Luquetti AO, Rassi A, Rassi GG, Chiari E, et al. (2002) Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol Res 88: 894-900.
13. Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES (2007) Evaluation of serological tests to identify human Trypanosoma cruzi infection and cross-reactivity with Trypanosoma rangeli and Leishmania spp cases. Clin Vaccine Immunol.
14. Silveira-Lacerda EP, Silva AG, Junior SF, Souza MA, Kesper N, et al. (2004) Chagas' disease: Application of TESA-blot in inconclusive scm from a Brazilian blood bank. Vox Sang 87: 204-207.
15. Wincker P, Britto C, Pereira JB, Cardoso MA, Oelemann W, et al. (1994) Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am J Trop Med Hyg 51: 771-777.
16. Gutierrez R, Angulo VM, Tarazona Z, Britto C, Fernandes O (2004) Comparison of four serological tests for the diagnosis of Chagas disease in a Colombian endemic area. Parasitology 129: 439-444.
17. Marcon GE, Andrade PD, de Albuquerque DM, Wanderley Jda S, de Almeida EA, et al. (2002) Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn Microbiol Infect Dis 43: 39-43.
18. Picka MC, Meira DA, de Carvalho TB, Peresi E, Marcondes-Machado J (2007) Definition of a diagnostic routine in individuals with inconclusive serology for Chagas disease. Braz J Infect Dis 11: 226-233.
19. Zarate-Blades CR, Blades N, Nascimento MS, da Silveira JF, Umezawa ES (2007) Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas' disease in Bolivia. Diagn Microbiol Infect Dis 57: 229-232.
20. Tobler LH, Contestable P, Pitina L, Groth H, Shaffer S, et al. (2007) Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. Transfusion 47: 90-96.
21. da Silveira JF, Umezawa ES, Luquetti AO (2001) Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol 17: 286-291.
22. Chang CD, Cheng KY, Jiang LX, Salbilla VA, Haller AS, et al. (2006) Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening. Transfusion 46: 1737-1744.
23. Kirchhoff LV, Hieny S, Shiver GM, Snary D, Sher A (1984) Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi. J Immunol 133: 2731-2735.
24. Laucella SA, Postan M, Mactin D, Fralish BH, Albareda MC, Alvarez MG, Lococo B, Barbeieri G, Viotti RJ, Tarleton RL (2004) Frequency of Interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infectious Diseases 189: 909-918.
25. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, et al. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 4: 1449-1452.
26. Ho A, Schwarze SR, Mermelstein SJ, Waltsman G, Dowdy SF (2001) Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo. Cancer Res 61: 474-477.
27. Cura EN, Segura EL (1998) Quality assurance of the serologic diagnosis of Chagas disease. Rev Panam Salud Publics 3: 242-248.
28. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, et al. (2006) Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: A nonrandomized trial. Ann Intern Med 144: 724-734.
29. Waterboer T, Sehr P, Pawlita M (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309: 200-204.
30. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, et al. (2005) The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309: 409-415.
31. Atwood JA 3rd, Weatherly DB, Minning TA, Bundy B, Cavola C, et al. (2005) The Trypanosoma cruzi proteome. Science 309: 473-476.
32. Salomone OA, Juri D, Omelianiuk MO, Sembaj A, Aguerri AM, et al. (2000) Prevalence of circulating Trypanosoma cruzi detected by polymerase chain reaction in patients with Chagas cardiomyopathy. Am J Cardiol 85: 1274-1276.
33. Duarte AM, de Andrade HM, do Monte SJ, de Toledo Vde P, Guimaraes TM (2006) Assessment of chemiluminescence and PCR effectiveness in relation to conventional serological tests for the diagnosis of Chagas' disease. Rev Soc Bras Med Trop 39: 385-387.
34. Silva ED, Pereira VR, Gomes JA, Lorena VM, Cancado JR, et al. (2002) Use of the EIE-recombinant-Chagas-biomanguinhos kit to monitor cure of human Chagas' disease. J Clin Lab Anal 16: 132-136.
35. Umezawa ES, Luquetti AO, Levitus G, Ponce C, Ponce E, et al. (2004) Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: Results of a collaborative study in six Latin American countries. J Clin Microbiol 42: 449-452.
36. Wincker P, Bosseno MF, Britto C, Yaksic N, Cardoso MA, et al. (1994) High correlation between Chagas' disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in an endemic area. Ferns Microbiol Lett 124: 419-423.
37. Sanchez Negrette O, Sanchez Valdez FJ, Lacunas CD, Garcia Bustos MF, Mora MC, et al. (2008) Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease. Clin Vaccine Immnunol 15: 297-902.
38. Bahia-Oliveira LM, Gomes JA, Cancado JR, Ferrari TC, Lemos EM, et al. (2000) Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J Infect Dis 182: 634-638.
39. Solari A, Ortiz S, Soto A, Arancibia C, Campillay R, et al. (2001) Treatment of Trypanosoma cruzi-infected children with nifurtimox: A 3 year follow-up by PCR. J Antimicrob Chemother 48: 513-519.
40. Krautz GM, Peterson JD, Godsel LM, Krettli AU, Engman DM (1998) Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins. Am J Trop Med Hyg 58: 137-143.
41. Davies DH, Molina DM, Wrammert J, Miller J, Hirst S, et al. (2007) Proteomewide analysis of the serological response to vaccinia and smallpox. Proteomics 7: 1678-1686.
42. Sundaresh S, Doolan DL, Hirst S, Mu Y, Unal B, et al. (2006) Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 22: 1760-1766.
43. Sundaresh S, Randall A, Unal B, Petersen JM, Belisle JT, et al. (2007) From protein microarrays to diagnostic antigen discovery: A study of the pathogen Francisella tularensis. Bioinformatics 23: I508-518.
44. Viotti R, Vigliano C, Armenti H, Segura E (1994) Treatment of chronic Chagas' disease with benznidazole: Clinical and serologic evolution of patients with long-term follow-up. Am Heart J 127: 151-162.
45. Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, et al. (1998) Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 59: 526-529.
46. Kartalov EP, Zhong JF, Scherer A, Quake SR, Taylor CR, et al. (2006) High-throughput multi-antigen microfluidic fluorescence immunoassays. Biotechniques 40: 85-90.